
New Therapeutics for Novel Problems through Collaboration - Dr. Betsy O'neill
Talking Biotech with Dr. Kevin Folta
00:00
Horizon Therapy
horizon therapy is very interesting in that we actually were built in the reverse direction. So our company was founded by a small group of folks with commercial expertise and they had an original drug to treat inflammatory pain. They reinvested that back into this rare disease model, you know, which is sort of 10 or 12 years ago,. And they started licensing in drugs that were approved for very rare, very serious diseases. We have a drug for very medicine for various of your gout, which was also in license to had just been approved but really needed some support to get it used right.
Transcript
Play full episode